Concepedia

Wen Ching Han

WC

Statistics

Publications

6

Citations

189

H-Index

6

Active since

1986

Affiliations

Bristol-Myers Squibb (United States)(Current)

Institute for Medical Research

Bristol-Myers Squibb (Sweden)

Wen Ching Han is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and pharmacotherapy.

Top concepts

Publications per year

1986–1993

6

Publications

6

Cupric bromide mediated oxidation of 4-carboxyoxazolines to the corresponding oxazoles

Joel C. Barrish, Janak Singh, Steven H. Spergel et al. · The Journal of Organic Chemistry · 1993 · 70 citations

, , +9

Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2(TxA2)antagonists. Semicarbazone .omega.-chains

Raj N. Misra, Baerbel R. Brown, Wen Ching Han et al. · Journal of Medicinal Chemistry · 1991 · 36 citations · Full text

, , +14

Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists

Raj N. Misra, Baerbel R. Brown, Philip M. Sher et al. · Journal of Medicinal Chemistry · 1993 · 28 citations · Full text

7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza .omega.-chain analogs

Masami Nakane, Joyce A. Reid, Wen Ching Han et al. · Journal of Medicinal Chemistry · 1990 · 22 citations · Full text

, , +16

9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenase

Steven E. Hall, Wen Ching Han, Martin F. Haslanger et al. · Journal of Medicinal Chemistry · 1986 · 17 citations

, , +16

1–5 of 6